Immatics director granted 48,000 stock options
Immatics N.V. director Mathias Hothum received a grant of 48,000 stock options to purchase Ordinary Shares at an exercise price of $9.09 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Immatics N.V. director Mathias Hothum received a grant of 48,000 stock options to purchase Ordinary Shares at an exercise price of $9.09 per share. These options vest 100% on June 16, 2026 and expire on June 15, 2036, leaving him holding 48,000 derivative securities directly.
This is a compensation-related award, not an open-market stock purchase or sale.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 48,000 | $0.00 | $0.00 |
Footnotes (1)
- F1. These Options vest 100% on the first anniversary of the grant date, June 16, 2026.
Key Figures
Key Terms
Stock Option (Right to Buy) financial
Grant, award, or other acquisition financial
vest 100% on the first anniversary financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Immatics (IMTX) director Mathias Hothum report on this Form 4?
What are the key terms of Mathias Hothum’s 48,000 Immatics (IMTX) options?
When do the Immatics (IMTX) options granted to Mathias Hothum vest and expire?
How many Immatics (IMTX) derivative securities does Mathias Hothum hold after this grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.